Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $767.21 | 40 | 79.6% |
| Education | $197.00 | 2 | 20.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $301.54 | 18 | $0 (2024) |
| ABBVIE INC. | $208.40 | 3 | $0 (2022) |
| Boston Scientific Corporation | $144.25 | 7 | $0 (2024) |
| PFIZER INC. | $79.70 | 2 | $0 (2018) |
| Ferring Pharmaceuticals Inc. | $37.42 | 2 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $34.41 | 1 | $0 (2017) |
| Allergan Inc. | $24.78 | 1 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $23.10 | 1 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $21.44 | 1 | $0 (2024) |
| Braintree Laboratories, Inc. | $19.13 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $120.42 | 7 | Janssen Biotech, Inc. ($50.92) |
| 2023 | $121.10 | 2 | Janssen Biotech, Inc. ($98.00) |
| 2022 | $94.50 | 1 | ABBVIE INC. ($94.50) |
| 2021 | $182.59 | 15 | Janssen Biotech, Inc. ($152.62) |
| 2020 | $16.69 | 1 | Boston Scientific Corporation ($16.69) |
| 2019 | $21.21 | 1 | Boston Scientific Corporation ($21.21) |
| 2018 | $218.32 | 8 | AbbVie, Inc. ($57.87) |
| 2017 | $189.38 | 7 | AbbVie, Inc. ($56.03) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: General - Biliary Devices_ENDO | ||||||
| 10/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: LIVER DISEASE | ||||||
| 09/11/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: EXALT Model D_ENDO | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Immunology | ||||||
| 06/10/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: CRITICAL CARE | ||||||
| 03/25/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Immunology | ||||||
| 08/26/2023 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Immunology | ||||||
| 08/10/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $98.00 | General |
| Category: Immunology | ||||||
| 07/21/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $94.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/10/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $2.52 | General |
| Category: Immunology | ||||||
| 09/30/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: Immunology | ||||||
| 08/31/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: Immunology | ||||||
| 08/17/2021 | BOSTON SCIENTIFIC CORPORATION | EXALT (Device) | Food and Beverage | Cash or cash equivalent | $29.97 | General |
| Category: EXALT | ||||||
| 08/10/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: Immunology | ||||||
| 08/05/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: Immunology | ||||||
| 06/23/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: Immunology | ||||||
| 06/01/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $4.26 | General |
| Category: Immunology | ||||||
| 05/21/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 05/13/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: Immunology | ||||||
| 05/04/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: Immunology | ||||||
| 04/26/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: Immunology | ||||||
| 04/20/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: Immunology | ||||||
| 03/04/2021 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI ARIA | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: Immunology | ||||||
| 02/17/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 613 | 659 | $314,282 | $71,599 |
| 2022 | 16 | 740 | 784 | $393,173 | $85,031 |
| 2021 | 19 | 737 | 793 | $273,084 | $80,297 |
| 2020 | 17 | 721 | 801 | $240,242 | $72,654 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 151 | 152 | $147,592 | $29,865 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 41 | $10,028 | $5,176 | 51.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 50 | $13,550 | $4,895 | 36.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 59 | 63 | $41,580 | $4,139 | 10.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 43 | $7,806 | $3,919 | 50.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 41 | 59 | $8,437 | $3,584 | 42.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 30 | 32 | $15,360 | $3,424 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 58 | $7,027 | $3,304 | 47.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $9,010 | $2,972 | 33.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 40 | 41 | $30,914 | $2,534 | 8.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $5,850 | $2,284 | 39.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $6,416 | $2,131 | 33.2% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 13 | 13 | $7,280 | $1,693 | 23.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 36 | 44 | $3,432 | $1,679 | 48.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 200 | 202 | $196,142 | $39,783 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 69 | $12,420 | $6,120 | 49.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 33 | 34 | $13,634 | $5,293 | 38.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 76 | 78 | $51,480 | $5,223 | 10.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 26 | 26 | $13,780 | $4,524 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 75 | $8,925 | $4,333 | 48.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 56 | $8,008 | $3,130 | 39.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 55 | 55 | $41,470 | $3,030 | 7.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 24 | $5,832 | $3,010 | 51.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 25 | 27 | $12,960 | $2,715 | 20.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $6,435 | $2,477 | 38.5% |
About Dr. Ryan Gaffney, DO
Dr. Ryan Gaffney, DO is a Gastroenterology healthcare provider based in Chambersburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2010. The National Provider Identifier (NPI) number assigned to this provider is 1003136664.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Gaffney, DO has received a total of $964.21 in payments from pharmaceutical and medical device companies, with $120.42 received in 2024. These payments were reported across 42 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($767.21).
As a Medicare-enrolled provider, Gaffney has provided services to 2,811 Medicare beneficiaries, totaling 3,037 services with total Medicare billing of $309,580. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Chambersburg, PA
- Active Since 06/07/2010
- Last Updated 10/18/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003136664
Products in Payments
- STELARA (Biological) $279.10
- SKYRIZI (Biological) $94.50
- Viekira (Drug) $56.03
- XELJANZ (Drug) $55.86
- XIFAXANIBSD (Drug) $34.41
- EXALT (Device) $29.97
- REMICADE (Biological) $26.46
- VIBERZI (Drug) $24.78
- INFLECTRA (Biological) $23.84
- CAPTIVATOR COLD (Device) $22.39
- CLENPIQ (Drug) $21.88
- TERLIVAZ (Drug) $21.44
- GENERAL GI DILATATION (Device) $21.21
- GENERAL ENDOCHOICE (Device) $19.99
- SUPREP (Drug) $19.13
- TREMFYA (Drug) $19.08
- EXALT Model D (Device) $17.37
- EXALT BX 2 (Device) $16.69
- Trulance (Drug) $15.65
- PREPOPIK (Drug) $15.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Chambersburg
Nathan Yeasted, M.d, M.D
Gastroenterology — Payments: $713.99
Dr. Wayne Hoover, M.d, M.D
Gastroenterology — Payments: $694.98
Dr. Mark Dobish, M.d, M.D
Gastroenterology — Payments: $419.15
Dr. John Enders, M.d, M.D
Gastroenterology